Loading the comparison…
Loading the comparison…
Any covered state and procedure, side by side
| Bronchoscopy & lung nodule · Michigan | Bronchoscopy & lung nodule · Illinois | |
|---|---|---|
| Surgeons, 2024 | 41 | 82 |
| Medicare fee-for-service cases | 2,711 | 5,581 |
| Growth since 2019 (Medicare FFS) | −0.1%/yr | +11%/yr |
| Forecast cases (Medicare FFS) | 4,390 in 2030 | 10,800 in 2030 |
| Forecast growth | +8.4%/yr to 2030 | +12%/yr to 2030 |
| Per 1,000 Medicare beneficiaries | 3.3 | 4.1 |
| Medicare Advantage share | 66% | 47% |
| Out of hospital | 0% (+0 pts since 2019) | 0% (+0 pts since 2019) |
| Cases per surgeon | 66 | 68 |
| Top 10 surgeons' share | 48% | 41% |
| Surgeons growing | 4 | 21 |
| New since the base year | 13 | 22 |
| Likely to stop billing it | 6 by 2026 | 11 by 2026 |
| Forecast miss, 1 year (procedure) | 6% | 6% |
| Company payments per surgeon | $6,934 | $11K |
The counts above are the surgeons MedaRep names: who is growing, who is new, who is likely to stop and which companies engage them.